A panel of 4 experts discussed the most favored nation (MFN) initiative and its impacts on research and development, market and payer distributions, and pharmacists and patients.
Neal Masia, PhD
Advertisement
Articles by Neal Masia, PhD
Advertisement
Latest Updated Articles
Decoding Most Favored Nation: Expert Insights on the Impacts to Patients, Pharma, and InnovationPublished: September 12th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Q&A: How 340B Rebate Pilot Could Strain Community Pharmacies and Patient Access
2
FDA Approves Roflumilast Cream for Pediatric Patients With Atopic Dermatitis
3
Tips for Using AI Tools Responsibly During Pharmacy School
4
Albuterol–Budesonide Combo Boosts Lung Function in Asthma
5
